ZYUS Life Sciences Corporation (ZYUS : TSX-V)
Common Stock
$0.50
CAD
+0.00 (%)
Last updated: 2026-08-21
Get ZYUS alerts:
ZYUS
ZYUS Life Sciences Corporation
WealthAwesomePerformance
1 Day
+0.00%
1 Week
+0.00%
1 Month
+0.00%
YTD
-26.47%
Key Statistics
Market Cap
$39.86M
52W High
$0.74
52W Low
$0.40
P/E Ratio
-
50 Day MA
$0.50
200 Day MA
$0.58
Beta
0.45
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 8/21/2026 | $0.50 | $0.50 | $0.50 | $0.50 | $0.50 | 0 |
| 8/20/2026 | $0.50 | $0.50 | $0.50 | $0.50 | $0.50 | 0 |
| 8/11/2026 | $0.50 | $0.50 | $0.50 | $0.50 | $0.50 | 0 |
| 7/9/2026 | $0.50 | $0.50 | $0.50 | $0.50 | $0.50 | 0 |
| 7/8/2026 | $0.50 | $0.50 | $0.50 | $0.50 | $0.50 | 0 |
| 7/6/2026 | $0.50 | $0.50 | $0.50 | $0.50 | $0.50 | 0 |
| 7/3/2026 | $0.50 | $0.50 | $0.50 | $0.50 | $0.50 | 0 |
| 7/2/2026 | $0.50 | $0.50 | $0.50 | $0.50 | $0.50 | 0 |
| 6/29/2026 | $0.50 | $0.50 | $0.50 | $0.50 | $0.50 | 0 |
| 6/16/2026 | $0.50 | $0.50 | $0.50 | $0.50 | $0.50 | 0 |
Analyst Price Targets
Based on analyst covering ZYUS
Wall Street analysts forecast ZYUS stock price to rise 200.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$1.50
+200.0% Upside
Current Price
C$0.50
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ZYUS's historical volatility
30-Day Vol
109.3%
Annualized
90-Day Vol
83.9%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.42
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.47 | C$0.32 – C$0.69 |
| 60 trading days | C$0.44 | C$0.26 – C$0.76 |
| 90 trading days | C$0.42 | C$0.22 – C$0.80 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About ZYUS Life Sciences Corporation
ZYUS Life Sciences Corporation manufactures and distributes cannabinoid-based therapeutics and product candidates for medical and adult recreational. The company offers Trichomylin, a softgel capsules with fixed dose combination of cannabinoids formulated that is phase 2a clinical trial for the treatment of chronic pain in adults caused due to musculoskeletal injuries, arthritis, and cancer. It operates in Canada, the United States, Australia, and the European Union. ZYUS Life Sciences Corporation was founded in 2018 and is headquartered in Saskatoon, Canada.
Financials
- Revenue (TTM)
- $413,000
- EBITDA
- $-11.32M
- Profit Margin
- 0.00%
- ROE (TTM)
- -3516.83%
- EPS (Diluted)
- -0.27
- Book Value
- -0.17
Classification
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About ZYUS
Market movers
Recent TSX-V movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| IRI | IEMR Resources Inc | $0.01 | +100.00% |
| PLY | Playfair Mining Ltd. | $0.09 | +63.64% |
| JADE | Jade Leader Corp | $0.01 | +50.00% |
| DELX | DelphX Capital Markets Inc | $0.01 | +50.00% |
| ATOM | Atomic Minerals Corp | $0.03 | +50.00% |
| GGAU | Galactic Gold Corp. | $0.19 | +35.71% |
| PTE | Pioneering Technology Corp | $0.02 | +33.33% |
| KIP | Kiplin Metals Inc | $0.27 | +32.50% |